Table 5. Static balance data for participants from the three groups at each evaluation (baseline: Evaluation 1; after 20 weeks: Evaluation 2; and after 40 weeks: Evaluation 3). Values are mean (Standard Error of Mean).
Variables CFTFG HG CG
E1 E2 E1 E2 E1 E2
Balance: Opened Eyes
  COP TTD (mm) 167.0 (18.4) 177.9 (19.4) 146.1 (19.7) 159.2 (20.9) 165.3 (16.5) 224.8 (18.0)*
  COP RA (mm2) 177.8 (70.4) 208.7 (73.6) 158.4 (75.2) 160.3 (79.2) 155.8 (62.9) 199.8 (67.9)
  COP APD (mm) 3.9 (.8) 3.8 (.8) 3.1 (.9) 3.2 (.9) 4.2 (.7) 4.7 (.8)
  COP MLD (mm) 2.8 (.5) 2.4 (.5) 2.1 (.5) 2.0 (.6) 2.1 (.4) 1.8 (.5)
Balance: Closed Eyes
  COP TTD (mm) 200.1 (34.5) 203.1 (35.5) 239.0 (36.9) 253.7 (38.2) 201.3 (30.9) 230.1 (32.5)
  COP RA (mm2) 204.6 (67.0) 203.1 (70.1) 184.9 (71.6) 200.9 (75.5) 147.7 (59.9) 148.0 (64.7)
  COP APD (mm) 3.0 (.9) 3.5 (.9) 4.2 (1.0) 4.0 (1.0) 3.2 (.8) 3.4 (.9)
  COP MLD (mm) 3.3 (.5) 2.7 (.5) 2.1 (.5) 2.4 (.5) 2.4 (.4) 2.3 (.5)
* Significant differences (p < 0.05) between E1 vs E2.CFTFG (combined face-to-face group); HG (home-based group); CG (control group); E (evaluation); COP (center of pressure); TTD (total travel distance); RA (radial area); APD (antero-posterior displacements); MLD (medio-lateral displacements).